StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Equities researchers at StockNews.com initiated coverage on shares of Milestone Scientific (NYSE:MLSS) in a report issued on Sunday. The firm set a “hold” rating on the stock.

Separately, Benchmark reissued a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.

Milestone Scientific Price Performance

NYSE MLSS opened at $1.02 on Friday. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The business has a fifty day moving average price of $0.83 and a two-hundred day moving average price of $0.87. The stock has a market capitalization of $79.06 million, a PE ratio of -14.50 and a beta of 1.10.

Insider Buying and Selling at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 24.75% of the company’s stock.

Hedge Funds Weigh In On Milestone Scientific

Hedge funds have recently modified their holdings of the company. Geode Capital Management LLC increased its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. World Investment Advisors LLC purchased a new stake in shares of Milestone Scientific during the 3rd quarter worth approximately $91,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the 3rd quarter worth approximately $48,000. Institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.